1. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;
2. Harvard Medical School, Boston, MA;
3. Department of Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany;
4. Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA;
5. Department of Laboratory Medicine, University of Washington, Seattle, WA;
6. Department of Data Science, Knowledge Systems Group, Boston, MA;
7. Center for Cancer Genome Discovery, Boston, MA;
8. Hematologic Neoplasia Flow Cytometry Core and
9. Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA;
10. Department of Pathology, Brigham and Women’s Hospital, Boston, MA; and
11. Department of Pathology and
12. Center for Cancer Research, Massachusetts General Hospital, Boston, MA